Service & Software
Global Neonatal Genetic Disease Diagnosis Market Research Report 2025
- Dec 02, 25
- ID: 640566
- Pages: 79
- Figures: 73
- Views: 2
This report aims to provide a comprehensive presentation of the global market for Neonatal Genetic Disease Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neonatal Genetic Disease Diagnosis.
The Neonatal Genetic Disease Diagnosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neonatal Genetic Disease Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neonatal Genetic Disease Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology
Segment by Type
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others
Segment by Application
Hospital
Medical Laboratory
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neonatal Genetic Disease Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Neonatal Genetic Disease Diagnosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neonatal Genetic Disease Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neonatal Genetic Disease Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology
Segment by Type
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others
Segment by Application
Hospital
Medical Laboratory
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neonatal Genetic Disease Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prenatal Diagnosis
1.2.3 Screening for Single Gene Genetic Disease
1.2.4 Preimplantation Genetic Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Neonatal Genetic Disease Diagnosis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Medical Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neonatal Genetic Disease Diagnosis Market Perspective (2020-2031)
2.2 Global Neonatal Genetic Disease Diagnosis Growth Trends by Region
2.2.1 Global Neonatal Genetic Disease Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neonatal Genetic Disease Diagnosis Historic Market Size by Region (2020-2025)
2.2.3 Neonatal Genetic Disease Diagnosis Forecasted Market Size by Region (2026-2031)
2.3 Neonatal Genetic Disease Diagnosis Market Dynamics
2.3.1 Neonatal Genetic Disease Diagnosis Industry Trends
2.3.2 Neonatal Genetic Disease Diagnosis Market Drivers
2.3.3 Neonatal Genetic Disease Diagnosis Market Challenges
2.3.4 Neonatal Genetic Disease Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neonatal Genetic Disease Diagnosis Players by Revenue
3.1.1 Global Top Neonatal Genetic Disease Diagnosis Players by Revenue (2020-2025)
3.1.2 Global Neonatal Genetic Disease Diagnosis Revenue Market Share by Players (2020-2025)
3.2 Global Neonatal Genetic Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neonatal Genetic Disease Diagnosis Revenue
3.4 Global Neonatal Genetic Disease Diagnosis Market Concentration Ratio
3.4.1 Global Neonatal Genetic Disease Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neonatal Genetic Disease Diagnosis Revenue in 2024
3.5 Global Key Players of Neonatal Genetic Disease Diagnosis Head office and Area Served
3.6 Global Key Players of Neonatal Genetic Disease Diagnosis, Product and Application
3.7 Global Key Players of Neonatal Genetic Disease Diagnosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neonatal Genetic Disease Diagnosis Breakdown Data by Type
4.1 Global Neonatal Genetic Disease Diagnosis Historic Market Size by Type (2020-2025)
4.2 Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Type (2026-2031)
5 Neonatal Genetic Disease Diagnosis Breakdown Data by Application
5.1 Global Neonatal Genetic Disease Diagnosis Historic Market Size by Application (2020-2025)
5.2 Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neonatal Genetic Disease Diagnosis Market Size (2020-2031)
6.2 North America Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neonatal Genetic Disease Diagnosis Market Size by Country (2020-2025)
6.4 North America Neonatal Genetic Disease Diagnosis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neonatal Genetic Disease Diagnosis Market Size (2020-2031)
7.2 Europe Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neonatal Genetic Disease Diagnosis Market Size by Country (2020-2025)
7.4 Europe Neonatal Genetic Disease Diagnosis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size (2020-2031)
8.2 Asia-Pacific Neonatal Genetic Disease Diagnosis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size by Region (2020-2025)
8.4 Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neonatal Genetic Disease Diagnosis Market Size (2020-2031)
9.2 Latin America Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neonatal Genetic Disease Diagnosis Market Size by Country (2020-2025)
9.4 Latin America Neonatal Genetic Disease Diagnosis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size (2020-2031)
10.2 Middle East & Africa Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (2020-2025)
10.4 Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Neonatal Genetic Disease Diagnosis Introduction
11.1.4 Abbott Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Details
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Neonatal Genetic Disease Diagnosis Introduction
11.2.4 PerkinElmer Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.2.5 PerkinElmer Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Details
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Neonatal Genetic Disease Diagnosis Introduction
11.3.4 Roche Diagnostics Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.3.5 Roche Diagnostics Recent Development
11.4 Bio Rad
11.4.1 Bio Rad Company Details
11.4.2 Bio Rad Business Overview
11.4.3 Bio Rad Neonatal Genetic Disease Diagnosis Introduction
11.4.4 Bio Rad Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.4.5 Bio Rad Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Neonatal Genetic Disease Diagnosis Introduction
11.5.4 Thermo Fisher Scientific Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 BGI Group
11.6.1 BGI Group Company Details
11.6.2 BGI Group Business Overview
11.6.3 BGI Group Neonatal Genetic Disease Diagnosis Introduction
11.6.4 BGI Group Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.6.5 BGI Group Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Details
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Neonatal Genetic Disease Diagnosis Introduction
11.7.4 Berry Genomics Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.7.5 Berry Genomics Recent Development
11.8 Da An Gene Co., Ltd.
11.8.1 Da An Gene Co., Ltd. Company Details
11.8.2 Da An Gene Co., Ltd. Business Overview
11.8.3 Da An Gene Co., Ltd. Neonatal Genetic Disease Diagnosis Introduction
11.8.4 Da An Gene Co., Ltd. Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.8.5 Da An Gene Co., Ltd. Recent Development
11.9 Illumina
11.9.1 Illumina Company Details
11.9.2 Illumina Business Overview
11.9.3 Illumina Neonatal Genetic Disease Diagnosis Introduction
11.9.4 Illumina Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.9.5 Illumina Recent Development
11.10 CapitalBio Technology
11.10.1 CapitalBio Technology Company Details
11.10.2 CapitalBio Technology Business Overview
11.10.3 CapitalBio Technology Neonatal Genetic Disease Diagnosis Introduction
11.10.4 CapitalBio Technology Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.10.5 CapitalBio Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prenatal Diagnosis
1.2.3 Screening for Single Gene Genetic Disease
1.2.4 Preimplantation Genetic Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Neonatal Genetic Disease Diagnosis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Medical Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neonatal Genetic Disease Diagnosis Market Perspective (2020-2031)
2.2 Global Neonatal Genetic Disease Diagnosis Growth Trends by Region
2.2.1 Global Neonatal Genetic Disease Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neonatal Genetic Disease Diagnosis Historic Market Size by Region (2020-2025)
2.2.3 Neonatal Genetic Disease Diagnosis Forecasted Market Size by Region (2026-2031)
2.3 Neonatal Genetic Disease Diagnosis Market Dynamics
2.3.1 Neonatal Genetic Disease Diagnosis Industry Trends
2.3.2 Neonatal Genetic Disease Diagnosis Market Drivers
2.3.3 Neonatal Genetic Disease Diagnosis Market Challenges
2.3.4 Neonatal Genetic Disease Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neonatal Genetic Disease Diagnosis Players by Revenue
3.1.1 Global Top Neonatal Genetic Disease Diagnosis Players by Revenue (2020-2025)
3.1.2 Global Neonatal Genetic Disease Diagnosis Revenue Market Share by Players (2020-2025)
3.2 Global Neonatal Genetic Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neonatal Genetic Disease Diagnosis Revenue
3.4 Global Neonatal Genetic Disease Diagnosis Market Concentration Ratio
3.4.1 Global Neonatal Genetic Disease Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neonatal Genetic Disease Diagnosis Revenue in 2024
3.5 Global Key Players of Neonatal Genetic Disease Diagnosis Head office and Area Served
3.6 Global Key Players of Neonatal Genetic Disease Diagnosis, Product and Application
3.7 Global Key Players of Neonatal Genetic Disease Diagnosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neonatal Genetic Disease Diagnosis Breakdown Data by Type
4.1 Global Neonatal Genetic Disease Diagnosis Historic Market Size by Type (2020-2025)
4.2 Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Type (2026-2031)
5 Neonatal Genetic Disease Diagnosis Breakdown Data by Application
5.1 Global Neonatal Genetic Disease Diagnosis Historic Market Size by Application (2020-2025)
5.2 Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neonatal Genetic Disease Diagnosis Market Size (2020-2031)
6.2 North America Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neonatal Genetic Disease Diagnosis Market Size by Country (2020-2025)
6.4 North America Neonatal Genetic Disease Diagnosis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neonatal Genetic Disease Diagnosis Market Size (2020-2031)
7.2 Europe Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neonatal Genetic Disease Diagnosis Market Size by Country (2020-2025)
7.4 Europe Neonatal Genetic Disease Diagnosis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size (2020-2031)
8.2 Asia-Pacific Neonatal Genetic Disease Diagnosis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size by Region (2020-2025)
8.4 Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neonatal Genetic Disease Diagnosis Market Size (2020-2031)
9.2 Latin America Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neonatal Genetic Disease Diagnosis Market Size by Country (2020-2025)
9.4 Latin America Neonatal Genetic Disease Diagnosis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size (2020-2031)
10.2 Middle East & Africa Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (2020-2025)
10.4 Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Neonatal Genetic Disease Diagnosis Introduction
11.1.4 Abbott Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Details
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Neonatal Genetic Disease Diagnosis Introduction
11.2.4 PerkinElmer Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.2.5 PerkinElmer Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Details
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Neonatal Genetic Disease Diagnosis Introduction
11.3.4 Roche Diagnostics Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.3.5 Roche Diagnostics Recent Development
11.4 Bio Rad
11.4.1 Bio Rad Company Details
11.4.2 Bio Rad Business Overview
11.4.3 Bio Rad Neonatal Genetic Disease Diagnosis Introduction
11.4.4 Bio Rad Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.4.5 Bio Rad Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Neonatal Genetic Disease Diagnosis Introduction
11.5.4 Thermo Fisher Scientific Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 BGI Group
11.6.1 BGI Group Company Details
11.6.2 BGI Group Business Overview
11.6.3 BGI Group Neonatal Genetic Disease Diagnosis Introduction
11.6.4 BGI Group Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.6.5 BGI Group Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Details
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Neonatal Genetic Disease Diagnosis Introduction
11.7.4 Berry Genomics Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.7.5 Berry Genomics Recent Development
11.8 Da An Gene Co., Ltd.
11.8.1 Da An Gene Co., Ltd. Company Details
11.8.2 Da An Gene Co., Ltd. Business Overview
11.8.3 Da An Gene Co., Ltd. Neonatal Genetic Disease Diagnosis Introduction
11.8.4 Da An Gene Co., Ltd. Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.8.5 Da An Gene Co., Ltd. Recent Development
11.9 Illumina
11.9.1 Illumina Company Details
11.9.2 Illumina Business Overview
11.9.3 Illumina Neonatal Genetic Disease Diagnosis Introduction
11.9.4 Illumina Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.9.5 Illumina Recent Development
11.10 CapitalBio Technology
11.10.1 CapitalBio Technology Company Details
11.10.2 CapitalBio Technology Business Overview
11.10.3 CapitalBio Technology Neonatal Genetic Disease Diagnosis Introduction
11.10.4 CapitalBio Technology Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025)
11.10.5 CapitalBio Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Prenatal Diagnosis
Table 3. Key Players of Screening for Single Gene Genetic Disease
Table 4. Key Players of Preimplantation Genetic Testing
Table 5. Key Players of Others
Table 6. Global Neonatal Genetic Disease Diagnosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Neonatal Genetic Disease Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Neonatal Genetic Disease Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Neonatal Genetic Disease Diagnosis Market Share by Region (2020-2025)
Table 10. Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Neonatal Genetic Disease Diagnosis Market Share by Region (2026-2031)
Table 12. Neonatal Genetic Disease Diagnosis Market Trends
Table 13. Neonatal Genetic Disease Diagnosis Market Drivers
Table 14. Neonatal Genetic Disease Diagnosis Market Challenges
Table 15. Neonatal Genetic Disease Diagnosis Market Restraints
Table 16. Global Neonatal Genetic Disease Diagnosis Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Neonatal Genetic Disease Diagnosis Market Share by Players (2020-2025)
Table 18. Global Top Neonatal Genetic Disease Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neonatal Genetic Disease Diagnosis as of 2024)
Table 19. Ranking of Global Top Neonatal Genetic Disease Diagnosis Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Neonatal Genetic Disease Diagnosis Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Neonatal Genetic Disease Diagnosis, Headquarters and Area Served
Table 22. Global Key Players of Neonatal Genetic Disease Diagnosis, Product and Application
Table 23. Global Key Players of Neonatal Genetic Disease Diagnosis, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Neonatal Genetic Disease Diagnosis Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Neonatal Genetic Disease Diagnosis Revenue Market Share by Type (2020-2025)
Table 27. Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Neonatal Genetic Disease Diagnosis Revenue Market Share by Type (2026-2031)
Table 29. Global Neonatal Genetic Disease Diagnosis Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Neonatal Genetic Disease Diagnosis Revenue Market Share by Application (2020-2025)
Table 31. Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Neonatal Genetic Disease Diagnosis Revenue Market Share by Application (2026-2031)
Table 33. North America Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Neonatal Genetic Disease Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Neonatal Genetic Disease Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Neonatal Genetic Disease Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Neonatal Genetic Disease Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Neonatal Genetic Disease Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Neonatal Genetic Disease Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbott Company Details
Table 49. Abbott Business Overview
Table 50. Abbott Neonatal Genetic Disease Diagnosis Product
Table 51. Abbott Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 52. Abbott Recent Development
Table 53. PerkinElmer Company Details
Table 54. PerkinElmer Business Overview
Table 55. PerkinElmer Neonatal Genetic Disease Diagnosis Product
Table 56. PerkinElmer Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 57. PerkinElmer Recent Development
Table 58. Roche Diagnostics Company Details
Table 59. Roche Diagnostics Business Overview
Table 60. Roche Diagnostics Neonatal Genetic Disease Diagnosis Product
Table 61. Roche Diagnostics Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 62. Roche Diagnostics Recent Development
Table 63. Bio Rad Company Details
Table 64. Bio Rad Business Overview
Table 65. Bio Rad Neonatal Genetic Disease Diagnosis Product
Table 66. Bio Rad Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 67. Bio Rad Recent Development
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Neonatal Genetic Disease Diagnosis Product
Table 71. Thermo Fisher Scientific Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Development
Table 73. BGI Group Company Details
Table 74. BGI Group Business Overview
Table 75. BGI Group Neonatal Genetic Disease Diagnosis Product
Table 76. BGI Group Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 77. BGI Group Recent Development
Table 78. Berry Genomics Company Details
Table 79. Berry Genomics Business Overview
Table 80. Berry Genomics Neonatal Genetic Disease Diagnosis Product
Table 81. Berry Genomics Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 82. Berry Genomics Recent Development
Table 83. Da An Gene Co., Ltd. Company Details
Table 84. Da An Gene Co., Ltd. Business Overview
Table 85. Da An Gene Co., Ltd. Neonatal Genetic Disease Diagnosis Product
Table 86. Da An Gene Co., Ltd. Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 87. Da An Gene Co., Ltd. Recent Development
Table 88. Illumina Company Details
Table 89. Illumina Business Overview
Table 90. Illumina Neonatal Genetic Disease Diagnosis Product
Table 91. Illumina Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 92. Illumina Recent Development
Table 93. CapitalBio Technology Company Details
Table 94. CapitalBio Technology Business Overview
Table 95. CapitalBio Technology Neonatal Genetic Disease Diagnosis Product
Table 96. CapitalBio Technology Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 97. CapitalBio Technology Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Neonatal Genetic Disease Diagnosis Picture
Figure 2. Global Neonatal Genetic Disease Diagnosis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neonatal Genetic Disease Diagnosis Market Share by Type: 2024 VS 2031
Figure 4. Prenatal Diagnosis Features
Figure 5. Screening for Single Gene Genetic Disease Features
Figure 6. Preimplantation Genetic Testing Features
Figure 7. Others Features
Figure 8. Global Neonatal Genetic Disease Diagnosis Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Neonatal Genetic Disease Diagnosis Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Medical Laboratory Case Studies
Figure 12. Others Case Studies
Figure 13. Neonatal Genetic Disease Diagnosis Report Years Considered
Figure 14. Global Neonatal Genetic Disease Diagnosis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Neonatal Genetic Disease Diagnosis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Neonatal Genetic Disease Diagnosis Market Share by Region: 2024 VS 2031
Figure 17. Global Neonatal Genetic Disease Diagnosis Market Share by Players in 2024
Figure 18. Global Top Neonatal Genetic Disease Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neonatal Genetic Disease Diagnosis as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Neonatal Genetic Disease Diagnosis Revenue in 2024
Figure 20. North America Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Neonatal Genetic Disease Diagnosis Market Share by Country (2020-2031)
Figure 22. United States Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Neonatal Genetic Disease Diagnosis Market Share by Country (2020-2031)
Figure 26. Germany Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Share by Region (2020-2031)
Figure 34. China Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Neonatal Genetic Disease Diagnosis Market Share by Country (2020-2031)
Figure 42. Mexico Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Neonatal Genetic Disease Diagnosis Market Share by Country (2020-2031)
Figure 46. Turkey Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abbott Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 50. PerkinElmer Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 51. Roche Diagnostics Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 52. Bio Rad Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 54. BGI Group Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 55. Berry Genomics Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 56. Da An Gene Co., Ltd. Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 57. Illumina Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 58. CapitalBio Technology Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Prenatal Diagnosis
Table 3. Key Players of Screening for Single Gene Genetic Disease
Table 4. Key Players of Preimplantation Genetic Testing
Table 5. Key Players of Others
Table 6. Global Neonatal Genetic Disease Diagnosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Neonatal Genetic Disease Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Neonatal Genetic Disease Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Neonatal Genetic Disease Diagnosis Market Share by Region (2020-2025)
Table 10. Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Neonatal Genetic Disease Diagnosis Market Share by Region (2026-2031)
Table 12. Neonatal Genetic Disease Diagnosis Market Trends
Table 13. Neonatal Genetic Disease Diagnosis Market Drivers
Table 14. Neonatal Genetic Disease Diagnosis Market Challenges
Table 15. Neonatal Genetic Disease Diagnosis Market Restraints
Table 16. Global Neonatal Genetic Disease Diagnosis Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Neonatal Genetic Disease Diagnosis Market Share by Players (2020-2025)
Table 18. Global Top Neonatal Genetic Disease Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neonatal Genetic Disease Diagnosis as of 2024)
Table 19. Ranking of Global Top Neonatal Genetic Disease Diagnosis Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Neonatal Genetic Disease Diagnosis Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Neonatal Genetic Disease Diagnosis, Headquarters and Area Served
Table 22. Global Key Players of Neonatal Genetic Disease Diagnosis, Product and Application
Table 23. Global Key Players of Neonatal Genetic Disease Diagnosis, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Neonatal Genetic Disease Diagnosis Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Neonatal Genetic Disease Diagnosis Revenue Market Share by Type (2020-2025)
Table 27. Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Neonatal Genetic Disease Diagnosis Revenue Market Share by Type (2026-2031)
Table 29. Global Neonatal Genetic Disease Diagnosis Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Neonatal Genetic Disease Diagnosis Revenue Market Share by Application (2020-2025)
Table 31. Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Neonatal Genetic Disease Diagnosis Revenue Market Share by Application (2026-2031)
Table 33. North America Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Neonatal Genetic Disease Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Neonatal Genetic Disease Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Neonatal Genetic Disease Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Neonatal Genetic Disease Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Neonatal Genetic Disease Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Neonatal Genetic Disease Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbott Company Details
Table 49. Abbott Business Overview
Table 50. Abbott Neonatal Genetic Disease Diagnosis Product
Table 51. Abbott Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 52. Abbott Recent Development
Table 53. PerkinElmer Company Details
Table 54. PerkinElmer Business Overview
Table 55. PerkinElmer Neonatal Genetic Disease Diagnosis Product
Table 56. PerkinElmer Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 57. PerkinElmer Recent Development
Table 58. Roche Diagnostics Company Details
Table 59. Roche Diagnostics Business Overview
Table 60. Roche Diagnostics Neonatal Genetic Disease Diagnosis Product
Table 61. Roche Diagnostics Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 62. Roche Diagnostics Recent Development
Table 63. Bio Rad Company Details
Table 64. Bio Rad Business Overview
Table 65. Bio Rad Neonatal Genetic Disease Diagnosis Product
Table 66. Bio Rad Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 67. Bio Rad Recent Development
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Neonatal Genetic Disease Diagnosis Product
Table 71. Thermo Fisher Scientific Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Development
Table 73. BGI Group Company Details
Table 74. BGI Group Business Overview
Table 75. BGI Group Neonatal Genetic Disease Diagnosis Product
Table 76. BGI Group Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 77. BGI Group Recent Development
Table 78. Berry Genomics Company Details
Table 79. Berry Genomics Business Overview
Table 80. Berry Genomics Neonatal Genetic Disease Diagnosis Product
Table 81. Berry Genomics Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 82. Berry Genomics Recent Development
Table 83. Da An Gene Co., Ltd. Company Details
Table 84. Da An Gene Co., Ltd. Business Overview
Table 85. Da An Gene Co., Ltd. Neonatal Genetic Disease Diagnosis Product
Table 86. Da An Gene Co., Ltd. Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 87. Da An Gene Co., Ltd. Recent Development
Table 88. Illumina Company Details
Table 89. Illumina Business Overview
Table 90. Illumina Neonatal Genetic Disease Diagnosis Product
Table 91. Illumina Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 92. Illumina Recent Development
Table 93. CapitalBio Technology Company Details
Table 94. CapitalBio Technology Business Overview
Table 95. CapitalBio Technology Neonatal Genetic Disease Diagnosis Product
Table 96. CapitalBio Technology Revenue in Neonatal Genetic Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 97. CapitalBio Technology Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Neonatal Genetic Disease Diagnosis Picture
Figure 2. Global Neonatal Genetic Disease Diagnosis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neonatal Genetic Disease Diagnosis Market Share by Type: 2024 VS 2031
Figure 4. Prenatal Diagnosis Features
Figure 5. Screening for Single Gene Genetic Disease Features
Figure 6. Preimplantation Genetic Testing Features
Figure 7. Others Features
Figure 8. Global Neonatal Genetic Disease Diagnosis Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Neonatal Genetic Disease Diagnosis Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Medical Laboratory Case Studies
Figure 12. Others Case Studies
Figure 13. Neonatal Genetic Disease Diagnosis Report Years Considered
Figure 14. Global Neonatal Genetic Disease Diagnosis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Neonatal Genetic Disease Diagnosis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Neonatal Genetic Disease Diagnosis Market Share by Region: 2024 VS 2031
Figure 17. Global Neonatal Genetic Disease Diagnosis Market Share by Players in 2024
Figure 18. Global Top Neonatal Genetic Disease Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neonatal Genetic Disease Diagnosis as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Neonatal Genetic Disease Diagnosis Revenue in 2024
Figure 20. North America Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Neonatal Genetic Disease Diagnosis Market Share by Country (2020-2031)
Figure 22. United States Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Neonatal Genetic Disease Diagnosis Market Share by Country (2020-2031)
Figure 26. Germany Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Share by Region (2020-2031)
Figure 34. China Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Neonatal Genetic Disease Diagnosis Market Share by Country (2020-2031)
Figure 42. Mexico Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Neonatal Genetic Disease Diagnosis Market Share by Country (2020-2031)
Figure 46. Turkey Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Neonatal Genetic Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abbott Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 50. PerkinElmer Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 51. Roche Diagnostics Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 52. Bio Rad Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 54. BGI Group Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 55. Berry Genomics Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 56. Da An Gene Co., Ltd. Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 57. Illumina Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 58. CapitalBio Technology Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Images Type AIGC Market Research Report 2025
Dec 02, 25
Global Screen Reading Tool for the Blind Market Research Report 2025
Dec 02, 25
Global Full Stack Perception Software Market Research Report 2025
Dec 02, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232